Liebers, N., Schönland, S., Speer, C., Edelmann, D., Schnitzler, P., Kräusslich, H., . . . Dietrich, S. (2022). Seroconversion rates after the second COVID-19 vaccination in patients with systemic light chain (AL) amyloidosis. HemaSphere, 6(3), . https://doi.org/10.1097/HS9.0000000000000688
Chicago Style (17th ed.) CitationLiebers, Nora, Stefan Schönland, Claudius Speer, Dominic Edelmann, Paul Schnitzler, Hans-Georg Kräusslich, Carsten Müller-Tidow, Ute Hegenbart, and Sascha Dietrich. "Seroconversion Rates After the Second COVID-19 Vaccination in Patients with Systemic Light Chain (AL) Amyloidosis." HemaSphere 6, no. 3 (2022). https://doi.org/10.1097/HS9.0000000000000688.
MLA (9th ed.) CitationLiebers, Nora, et al. "Seroconversion Rates After the Second COVID-19 Vaccination in Patients with Systemic Light Chain (AL) Amyloidosis." HemaSphere, vol. 6, no. 3, 2022, https://doi.org/10.1097/HS9.0000000000000688.